King Hussein Cancer Center
Clinical trials sponsored by King Hussein Cancer Center, explained in plain language.
-
Hospital-Made cancer fighters: new CAR-T trial for leukemia
Disease control Recruiting nowThis study is testing whether a personalized cell therapy called MB-CART19.1 can be manufactured right at the hospital for children and adults with B-cell acute lymphoblastic leukemia that has come back or not responded to standard treatments. The therapy uses the patient's own i…
Phase: NA • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on tough lymphoma in new trial
Disease control Recruiting nowThis phase II trial is testing a personalized cell therapy called MB-CART19.1 in 26 adults with CD19-positive non-Hodgkin lymphoma that has relapsed or not responded to prior treatments. The therapy uses a patient's own immune cells, which are modified in the lab to recognize and…
Phase: PHASE2 • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC